Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Turecek

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 5, 2023
In vitro field study and worldwide survey assessing how clinical haemostasis laboratories analyse recombinant and plasma-derived von Willebrand factor productsPeter L Turecek, Reinhard Ilk, Herbert Gritsch
Bio-Protocol|October 6, 2022
Von Willebrand Factor Multimer Analysis by Low Resolution SDS-Agarose Gel ElectrophoresisHerbert Gritsch, Margit Stimpfl, Peter L Turecek
Vox Sanguinis|March 17, 2022
Plasma procurement and plasma product safety in light of the COVID-19 pandemic from the perspective of the plasma industryPeter L Turecek, Deborah Hibbett, Thomas R Kreil
Seminars in Thrombosis and Hemostasis|May 7, 2002
Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factorPeter L Turecek, Jürgen Siekmann, Hans Peter Schwarz
Thrombosis and Haemostasis|September 28, 2002
The 1st International Standard for von Willebrand Factor concentrate: more to come?Hans P Schwarz, Bruce Ewenstein, Peter L Turecek
Current Hematology Reports|September 3, 2004
Update on the mechanism of action and future of activated prothrombin complex concentratesPeter L Turecek, Katalin Váradi, Hans Peter Schwarz
Vox Sanguinis|June 10, 2021
Biochemical and cellular markers differentiate recovered, in-line filtered plasma, and plasma obtained by apheresis methodsJürgen Siekmann, Alfred Weber, Christoph Bauer, et al.
Vox Sanguinis|July 30, 2021
Reply to Farrugia: Appropriately specifying the quality of plasma for fractionationJürgen Siekmann, Alfred Weber, Christoph Bauer, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 24, 2015
Development of a lectin binding assay to differentiate between recombinant and endogenous proteins in pharmacokinetic studies of protein-biopharmaceuticalsAlfred Weber, Eva Minibeck, Friedrich Scheiflinger, et al.
Journal of Pharmaceutical Sciences|October 20, 2019
Polysialic Acid-Mediated Activity Measurement of Polysialylated Recombinant Coagulation Factor VIIIAlfred Weber, Andrea Engelmaier, Jürgen Siekmann, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 5, 2023
In vitro field study and worldwide survey assessing how clinical haemostasis laboratories analyse recombinant and plasma-derived von Willebrand factor productsPeter L Turecek, Reinhard Ilk, Herbert Gritsch
Bio-Protocol|October 6, 2022
Von Willebrand Factor Multimer Analysis by Low Resolution SDS-Agarose Gel ElectrophoresisHerbert Gritsch, Margit Stimpfl, Peter L Turecek
Vox Sanguinis|March 17, 2022
Plasma procurement and plasma product safety in light of the COVID-19 pandemic from the perspective of the plasma industryPeter L Turecek, Deborah Hibbett, Thomas R Kreil
Seminars in Thrombosis and Hemostasis|May 7, 2002
Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factorPeter L Turecek, Jürgen Siekmann, Hans Peter Schwarz
Thrombosis and Haemostasis|September 28, 2002
The 1st International Standard for von Willebrand Factor concentrate: more to come?Hans P Schwarz, Bruce Ewenstein, Peter L Turecek
Current Hematology Reports|September 3, 2004
Update on the mechanism of action and future of activated prothrombin complex concentratesPeter L Turecek, Katalin Váradi, Hans Peter Schwarz
Vox Sanguinis|June 10, 2021
Biochemical and cellular markers differentiate recovered, in-line filtered plasma, and plasma obtained by apheresis methodsJürgen Siekmann, Alfred Weber, Christoph Bauer, et al.
Vox Sanguinis|July 30, 2021
Reply to Farrugia: Appropriately specifying the quality of plasma for fractionationJürgen Siekmann, Alfred Weber, Christoph Bauer, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 24, 2015
Development of a lectin binding assay to differentiate between recombinant and endogenous proteins in pharmacokinetic studies of protein-biopharmaceuticalsAlfred Weber, Eva Minibeck, Friedrich Scheiflinger, et al.
Journal of Pharmaceutical Sciences|October 20, 2019
Polysialic Acid-Mediated Activity Measurement of Polysialylated Recombinant Coagulation Factor VIIIAlfred Weber, Andrea Engelmaier, Jürgen Siekmann, et al.
Pageof 10